Antigenicity of a fetal extract in the leucocyte migration-inhibition test. 1983

Y Uehara, and O Kojima, and N Kitagawa, and A Oh, and B Nishioka, and Y Fujita, and S Majima

Leucocytes from patients with gastric or colorectal cancer as well as from normal subjects were tested by the leucocyte migration-inhibition test against 3 M KCl extracts of three whole fetuses and eight fetal gastrointestinal tract tissues. The incidence of pathologic results in patients with gastric and colorectal cancer was 26% (25/77) and 34% (25/74), respectively. The values were significantly higher than those of normal subjects (3%, 1/30). No significant difference in the migration index was found between whole fetal and fetal gastrointestinal tract extracts. The migration index did not depend on CEA concentration in these fetal extracts. These results show that leucocytes from patients with gastric or colorectal cancer were sensitized to antigenic substance(s) in the fetal extracts, and suggest that gastrointestinal cancer and fetal tissue may share some common antigens.

UI MeSH Term Description Entries
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002464 Cell Migration Inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Chemotaxis Inhibition,Chemotaxis Inhibitions,Inhibition, Chemotaxis,Inhibitions, Chemotaxis
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Uehara, and O Kojima, and N Kitagawa, and A Oh, and B Nishioka, and Y Fujita, and S Majima
October 1977, Ophthalmic surgery,
Y Uehara, and O Kojima, and N Kitagawa, and A Oh, and B Nishioka, and Y Fujita, and S Majima
May 1973, Lancet (London, England),
Y Uehara, and O Kojima, and N Kitagawa, and A Oh, and B Nishioka, and Y Fujita, and S Majima
April 1983, Gut,
Y Uehara, and O Kojima, and N Kitagawa, and A Oh, and B Nishioka, and Y Fujita, and S Majima
October 1975, Clinical and experimental immunology,
Y Uehara, and O Kojima, and N Kitagawa, and A Oh, and B Nishioka, and Y Fujita, and S Majima
March 1976, Deutsche medizinische Wochenschrift (1946),
Y Uehara, and O Kojima, and N Kitagawa, and A Oh, and B Nishioka, and Y Fujita, and S Majima
June 1978, Indian journal of cancer,
Y Uehara, and O Kojima, and N Kitagawa, and A Oh, and B Nishioka, and Y Fujita, and S Majima
November 1979, Transplantation,
Y Uehara, and O Kojima, and N Kitagawa, and A Oh, and B Nishioka, and Y Fujita, and S Majima
October 1980, The Indian journal of medical research,
Y Uehara, and O Kojima, and N Kitagawa, and A Oh, and B Nishioka, and Y Fujita, and S Majima
March 1978, Clinical and experimental immunology,
Y Uehara, and O Kojima, and N Kitagawa, and A Oh, and B Nishioka, and Y Fujita, and S Majima
June 1987, The Journal of communicable diseases,
Copied contents to your clipboard!